With a blood pressure of 150/90 mmHg, should I continue amlodipine (AmLong) 2.5 mg in this patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, you should increase the amlodipine dose to 5 mg daily

With a blood pressure of 150/90 mmHg on amlodipine 2.5 mg, you need to uptitrate the medication—the current dose is insufficient and the patient remains hypertensive.

Why This Blood Pressure Requires Action

Your patient has Grade 1 hypertension (BP 140-159/90-99 mmHg) that is uncontrolled on current therapy 1. The 2020 ISH guidelines clearly state that BP control should be achieved within 3 months of initiating treatment, with a target of <140/90 mmHg at minimum (ideally <130/80 mmHg) 1. The 2024 ESC guidelines similarly recommend BP targets below these thresholds 2.

The Dose Escalation Strategy

Amlodipine 2.5 mg is a low starting dose, and the evidence strongly supports dose titration:

  • Standard effective dosing: Clinical trials demonstrate that 2.5 mg is the minimum effective dose, but 5-10 mg provides significantly greater BP reduction 3
  • Dose-response relationship: After 4 weeks at 2.5 mg, if target BP is not achieved, escalation to 5 mg is the appropriate next step 4, 3
  • Expected BP reduction: Increasing from 2.5 mg to 5 mg can provide an additional 10-15 mmHg systolic reduction, which would bring your patient close to or at target 4, 5

The 2020 ISH guidelines explicitly recommend increasing to full dose of calcium channel blockers (like amlodipine) as step 2 in their treatment algorithm when initial low-dose therapy is insufficient 1.

Evidence Supporting This Approach

A 2018 study specifically evaluated S-amlodipine dose escalation from 2.5 mg to 5 mg: BP control rates increased from 53% at 2.5 mg to 78% at 5 mg after dose titration 4. The multicentric 2004 trial confirmed that amlodipine 5 mg (or S-amlodipine 2.5 mg equivalent) produces highly significant reductions in both systolic and diastolic BP across all positions 5.

Safety Considerations

  • Tolerability: Amlodipine 5 mg is well-tolerated, with side effects (edema, palpitations, dizziness, flushing) being more common at 10 mg doses 6
  • Long half-life advantage: Amlodipine's 35-50 hour half-life means BP control is maintained even if a dose is missed, providing continuous protection 6
  • Elderly patients: Even in elderly hypertensive patients (65-73 years), amlodipine 2.5-10 mg daily was safe and effective, with significant BP reductions at all doses 7

Common Pitfalls to Avoid

  1. Therapeutic inertia: Don't continue an inadequate dose hoping BP will eventually normalize—it won't 2
  2. Premature combination therapy: Before adding a second agent, maximize the first-line medication (amlodipine can go up to 10 mg if needed) 1
  3. Ignoring home BP monitoring: Confirm this office reading with home BP measurements to rule out white coat effect 1

Next Steps

  1. Increase amlodipine to 5 mg once daily immediately
  2. Recheck BP in 2-4 weeks to assess response 1
  3. If BP remains ≥140/90 mmHg on 5 mg, consider further escalation to 10 mg or adding a second agent (ACE inhibitor/ARB or thiazide diuretic) per ISH guidelines 1
  4. Target BP <140/90 mmHg (or <130/80 mmHg if high cardiovascular risk) 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.